FONDAZIONE TELETHON - Italy 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:600-700
2018
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:500-600
Networking Rank (Reputation):300-400
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:100-200
Total Number of Projects:63
Total Project Funding:300-400
Networking Rank (Reputation):700-800
Networking Rank (Reputation):700-800
Partner Constancy:46
Project Leadership Index:38
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
Total Project Funding:800-900
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:100-200
Total Number of Projects:500-600
Total Project Funding:200-300
Networking Rank (Reputation):900-1000
Partner Constancy:100-200
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:500-600
Total Number of Projects:600-700
Total Project Funding:900-1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:300-400
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:400-500
Total Number of Projects:500-600
Total Project Funding:800-900
Networking Rank (Reputation):700-800
Partner Constancy:> 1000
Project Leadership Index:98
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:500-600
Total Project Funding:200-300
Networking Rank (Reputation):500-600
Partner Constancy:> 1000
Project Leadership Index:200-300
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 41
As coordinator: 6
As participant: 27
Sole participant: 8
Coordinator / Participant Ratio: 0.22*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 10.401.956 593.750 1
2022 4.000.000 0 1.142.600 1
2021 150.000 0 120.000 1
2020 0 1.691.438 250.938 1
2019 15.145.830 56.223.831 6.202.383 2 3
2018 7.676.043 4.744.287 4.167.237 3 2
2017 2.975.345 2.838.930 2.292.305 1 3
2016 2.421.527 8.358.331 5.350.337 2 2
2014 100.000 0 100.000 1
2013 0 11.354.840 1.625.110 2
2012 8.189.204 21.851.677 7.188.168 2 6
2011 0 14.936.899 940.431 2
2010 232.902 32.737.663 3.797.954 1 5
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE7
EUROPEAN MOLECULAR BIOLOGY LABORATORY6
STICHTING KATHOLIEKE UNIVERSITEIT4
UNIVERSITY COLLEGE LONDON4
EBERHARD KARLS UNIVERSITAET TUEBINGEN3
KAROLINSKA INSTITUTE3
KING'S COLLEGE LONDON3
THE UNIVERSITY OF MANCHESTER3
UNIVERSITAET ZUERICH3
UNIVERSITY OF LEEDS3
ACONDICIONAMIENTO TARRASENSE ASSOCIACION2
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM2
BIOBYTE SOLUTIONS2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
FONDATION MALADIES RARES2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR2
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA2
FONDAZIONE SANTA LUCIA2
GENETHON2
GENOSAFE SAS2
HACETTEPE UNIVERSITESI2
INSTITUTO DE SALUD CARLOS III2
ISTITUTO SUPERIORE DI SANITA2
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT2
JOHANNES GUTENBERG UNIVERSITAET MAINZ2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
MEDICAL RESEARCH COUNCIL2
THE UNIVERSITY OF EDINBURGH2
THE UNIVERSITY OF SHEFFIELD2
THE UNIVERSITY OF TUEBINGEN2
UNIVERSIDAD POMPEU FABRA2
UNIVERSITA DEGLI STUDI DI MILANO BICOCCA2
UNIVERSITa DEGLI STUDI DI NAPOLI 'FEDERICO II'2
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II2
UNIVERSITA DEGLI STUDI DI TRENTO2
UNIVERSITAETSKLINIKUM FREIBURG2
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI2
UNIVERSITEIT GENT2
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN2
UNIVERSITY OF NEWCASTLE UPON TYNE2
UPPSALA UNIVERSITET2
WEIZMANN INSTITUTE OF SCIENCE2
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER2
20MED THERAPEUTICS BV1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACCELERON MEDICINES1
ACIBADEM MEHMET ALI AYDINLAR UNIVERSITY1
ACIES SAS1
ACUREOMICS AB1
AGENCE NATIONALE DE LA RECHERCHE1
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
AMSTERDAM MOLECULAR THERAPEUTICS BV1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES1
ASS FRANCAISE CONTRE LES MYOPATHIES1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASSOCIATION POUR LA RECHERCHE ET LE DEVELOPPEMENT DES METHODES ET PROCESSUS INDUSTRIELS1
AUSTRIAN RESEARCH CENTERS SIEBERDORF1
AVACTA LIFE SCIENCES LIMITED1
AZIENDA OSPEDALIERA UNIVERSITARIA SENESE1
AZIENDA OSPEDALIERO UNIVERSITARIA PISANA1
AZIENDA SANITARIA UNIVERSITARIA FRIULI CENTRALE1
BATTEN DISEASE FAMILY ASSOCIATION1
BGI SHENZHEN LIFE SCIENCE RESEARCH INSTITUTION1
BIOTESYS1
BLACKSWAN FOUNDATION1
CAMBRIDGE CELL NETWORKS1
CANADIAN INSTITUTES OF HEALTH RESEARCH1
CANCER HOSPITAL OF CHINESE ACADEMYOF MEDICAL SCIENCES1
CELL THERAPY CATAPULT LIMITED1
CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD1
CENTRE DE REGULACIO GENOMICA1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CENTRO DE INVESTIGACION BIOMEDICA EN RED1
CHRONOS BIOSYSTEMS1
CINFERENCE UG1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE1
CORETHERAPIX SL1
DANDO WEISS & COLUCCI LIMITED1
DANMARKS TEKNISKE UNIVERSITET1
DEPARTMENT OF HEALTH GOVERNMENT OF WESTERN AUSTRALIA1
DEUTSCHE FORSCHUNGSGEMEINSCHAFT1
DEUTSCHES ZENTRUM FUR LUFT UND RAUMFAHRT EV1
DRESDEN UNIVERSITY OF TECHNOLOGY1
DUKE UNIVERSITY1
EATRIS ERIC1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
EIDGENOESSISCHE MATERIALPRUEFUNGS UND FORSCHUNGSANSTALT1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
EUROPEAN ORGANISATION FOR RARE DISEASES1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
EUROPEAN VISION INSTITUTE EEIG1
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION1
EVOLVA1
F HOFFMANNLA ROCHE1
FAUN STIFTUNG NURNBERG1

Constancy:

Total number of partners: 359
Partner loyalty:
Frequent Partner: (> 2 projects): 39
Rare Partner: 320
Frequent / Rare Partner Ratio: 0.12

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01Building REsilience against MEntal illness during ENDocrine-sensitive life stages Re-MENDparticipant10.401.95616
2022-10-01Next-generation AAV vectors for liver-directed gene therapy AAVolutioncoordinator4.000.0009
2021-01-01Pharmacological restoration of selective autophagy for the treatment of skeletal disorders RE-STOREcoordinator150.0002
2020-01-01Integrating China in the International Consortium for Personalised Medicine IC2PerMedparticipant1.691.43811
2019-06-01Moving a novel gene therapy paradigm to treat blindness to the market inSightparticipant150.0002
2019-03-01RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients RESTOREparticipant1.000.00011
2019-01-01Unlocking Precision Gene Therapy UPGRADEcoordinator14.995.8308
2019-01-01a rapid and efficient method for generation of iPSC EASY-IPScoordinator150.0001
2019-01-01European Joint Programme on Rare Diseases EJP RDparticipant55.073.83188
2018-11-01Excel in Rare Diseases’ Research: Focus on LYSOsomal Disorders and CILiopathies LYSOCILparticipant967.5733
2018-10-01European Training Network to Diagnose, Understand and Treat Stargardt Disease, a Frequent Inherited Blinding Disorder StarTparticipant3.776.71415
2018-04-01Deciphering the Transcriptional Logic of TFEB activation in cell identity and cancer EpiTFebcoordinator180.2771
2018-03-01Dissecting the regulatory logic of cell fate reprogramming through integrative and single cell genomics CellKarmacoordinator1.497.2501
2018-01-01Clinical trial of gene therapy with dual AAV vectors for retinitis pigmentosa in patients with Usher syndrome type IB UshThercoordinator5.998.5169
2017-10-01Control Engineering of Biological Systems for Reliable Synthetic Biology Applications COSY-BIOcoordinator2.975.3458
2017-04-01Developing a cure for retinitis pigmentosa due to Usher syndrome GeneVisionparticipant150.0001
2017-03-01Genetic and Small Molecule Modifiers of Lysosomal Function LysoModparticipant1.102.50014
2017-01-01Defining the role of the FGF – autophagy axis in bone physiology BONEPHAGYparticipant1.586.4301
2016-10-01Functional Genomics of the Lysosome LYSOSOMICSparticipant2.362.5631
2016-01-01Systems Biology of Membrane Trafficking SYSMETcoordinator2.241.2501
2016-01-01Exploring the role of TFEB in exosome biology and in novel approaches for treatment of lysosomal diseases REBuILDcoordinator180.2771
2016-01-01Developing new therapies for Batten disease BATCureparticipant5.995.76914
2014-01-01Identification of molecular targets for the treatment of the skeletal phenotype in Lysosomal Storage Disorders .BLASTED2coordinator100.0001
2013-04-01Biological Foundation for the Safety Classification of Engineered Nanomaterials (ENM): Systems Biology Approaches to Understand Interactions of ENM with Living Organisms and the Environment NANOSOLUTIONSparticipant10.000.00037
2013-02-01DNA binding proteins for treatment of gain of function mutations ALLELECHOKERparticipant1.354.8401
2012-12-01DULBECCO TELETHON INSTITUTE-INTERNATIONAL MOBILITY FOR POSTDOCTORAL RESEARCH TRAINING DTI-IMPORTcoordinator2.194.1631
2012-12-01Rapid development and distribution of statistical tools for high-throughput sequencing data RADIANTparticipant3.672.24910
2012-12-01Clinical trial of gene therapy for MPS VI - a severe lysosomal storage disorder MEUSIXcoordinator5.995.0418
2012-11-01Therapies for inborn errors of metabolism IEMTXparticipant1.491.5201
2012-11-01Beyond the Genome; training the next generation of ophthalmic researchers EYETNparticipant3.090.7977
2012-11-01"RD-CONNECT: An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research" RD-CONNECTparticipant11.997.11127
2012-06-01Search for novel molecules cross-talking between muscle and cancer with therapeutic potential against cachexia and cancer muscleandcancerparticipant100.0002
2012-01-01Overcoming the challenge of large gene transfer for the therapy of inherited retinal diseases RETGENTXparticipant1.500.0001
2011-10-01From Data to Models: New Bioinformatics Methods and Tools for Data-Driven Predictive Dynamic Modelling in Biotechnological Applications BIOPREDYNparticipant3.000.00012
2011-01-01Systems biology of liver cancer: an integrative genomic-epigenomic approach MODHEPparticipant11.936.89918
2010-12-01Targeting glucocorticoid resistance in T-ALL: a Systems Biology approach TiGRecoordinator232.9021
2010-06-01A systems biology approach to dissect cilia function and its disruption in human genetic disease SYSCILIAparticipant11.069.08317
2010-03-01Modulating cellular clearance to cure human disease CLEARparticipant2.100.0001
2010-02-01"Fighting blindness of Usher syndrome: diagnosis, pathogenesis and retinal treatment (TreatRetUsher)" TREATRUSHparticipant6.000.00013
2010-01-01Wnt/beta-Catenin Signalling Pathway Controls Reprogramming: The Basis Of Regeneration In Higher Vertebrates REREparticipant1.571.0002
2010-01-01Activation of vasculature associated stem cells and muscle stem cells for the repair and maintenance of muscle tissue Endostemparticipant11.997.58022

Alias institution names:

  • FONDAZIONE TELETHON
  • FONDAZIONE TELETHON ETS